ALLO — ALLOGENE THERAPEUTICS INC

Ownership history in Engineers Gate Manager LP  ·  10 quarters on record

This page tracks every 13F SEC filing in which Engineers Gate Manager LP reported a position in ALLOGENE THERAPEUTICS INC (ALLO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2022 Q4)
Avg. % of fund
0.02%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 36,446 +3,981 +12.3% 0.00% $45K $1.24
2025 Q2 REDUCED 32,465 -15,308 -32.0% 0.00% $37K $1.13
2024 Q3 REDUCED 47,773 -47,973 -50.1% 0.00% $134K $2.80
2023 Q2 REDUCED 95,746 -5,619 -5.5% 0.02% $476K $4.97
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ALLO price (monthly, adj. close)

Other funds also holding ALLO

As of 2025 Q4 — sorted by position size

PFIZER INC 12.76% Wildcat Capital Management, LLC 3Y 7Y 2.93% Patient Square Capital LP 3Y 1.46% TPG GP A, LLC 3Y 0.95% DAFNA Capital Management LLC 3Y 7Y 0.44% Frazier Life Sciences Management, L.P. 3Y 0.14% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% Virtus Investment Advisers, LLC 3Y 7Y 0.07% Woodline Partners LP 3Y 0.02% XTX Topco Ltd 3Y 0.02%
← Back to Engineers Gate Manager LP Holdings